Hulot JS - Search Results

1

Clustering of acute and subacute stent thrombosis related to the introduction of generic clopidogrel.

Kovacic JC, Mehran R, Sweeny J, Li JR, Moreno P, Baber U, Krishnan P, Badimon JJ, Hulot JS, Kini A, Sharma SK. Kovacic JC, et al. Among authors: hulot js. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):201-8. doi: 10.1177/1074248413510605. Epub 2013 Nov 22. J Cardiovasc Pharmacol Ther. 2014. PMID: 24271136

2

An allele-specific PCR system for rapid detection and discrimination of the CYP2C19∗4A, ∗4B, and ∗17 alleles: implications for clopidogrel response testing.

Scott SA, Tan Q, Baber U, Yang Y, Martis S, Bander J, Kornreich R, Hulot JS, Desnick RJ. Scott SA, et al. Among authors: hulot js. J Mol Diagn. 2013 Nov;15(6):783-9. doi: 10.1016/j.jmoldx.2013.06.004. Epub 2013 Sep 5. J Mol Diagn. 2013. PMID: 24012947 Free article.

3

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Yang Y, Lewis JP, Hulot JS, Scott SA. Yang Y, et al. Among authors: hulot js. Expert Opin Drug Metab Toxicol. 2015;11(10):1599-617. doi: 10.1517/17425255.2015.1068757. Epub 2015 Jul 14. Expert Opin Drug Metab Toxicol. 2015. PMID: 26173871 Free PMC article. Review.

4

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes.

Hulot JS, Stillitano F, Salem JE, Kovacic JC, Fuster V, Hajjar RJ. Hulot JS, et al. Stem Cell Res Ther. 2014 Jan 9;5(1):1. doi: 10.1186/scrt390. Stem Cell Res Ther. 2014. PMID: 24405778 Free PMC article. Review.

5

Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?

Knauer MJ, Diamandis EP, Hulot JS, Kim RB, So DY. Knauer MJ, et al. Among authors: hulot js. Clin Chem. 2015 Oct;61(10):1235-40. doi: 10.1373/clinchem.2015.238105. Epub 2015 Aug 13. Clin Chem. 2015. PMID: 26272232 No abstract available.

6

Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.

Hulot JS, Collet JP, Montalescot G. Hulot JS, et al. Curr Cardiol Rep. 2011 Oct;13(5):451-8. doi: 10.1007/s11886-011-0206-1. Curr Cardiol Rep. 2011. PMID: 21826477 Review.

7

PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.

Mega JL, Close SL, Wiviott SD, Man M, Duvvuru S, Walker JR, Sundseth SS, Collet JP, Delaney JT, Hulot JS, Murphy SA, Paré G, Price MJ, Sibbing D, Simon T, Trenk D, Antman EM, Sabatine MS. Mega JL, et al. Among authors: hulot js. J Thromb Thrombolysis. 2016 Apr;41(3):374-83. doi: 10.1007/s11239-015-1264-9. J Thromb Thrombolysis. 2016. PMID: 26573179

8

Antiplatelet and anticoagulation therapy for acute coronary syndromes.

Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA. Bhatt DL, et al. Among authors: hulot js. Circ Res. 2014 Jun 6;114(12):1929-43. doi: 10.1161/CIRCRESAHA.114.302737. Circ Res. 2014. PMID: 24902976 Review.

9

Clopidogrel and CYP2C19 testing: ready for clinical prime time?

Hulot JS, Hajjar R, Montalescot G. Hulot JS, et al. Clin Chem. 2012 Jan;58(1):154-7. doi: 10.1373/clinchem.2011.165829. Epub 2011 Sep 22. Clin Chem. 2012. PMID: 21940658 No abstract available.

10

Antiplatelet drug interactions with proton pump inhibitors.

Scott SA, Owusu Obeng A, Hulot JS. Scott SA, et al. Among authors: hulot js. Expert Opin Drug Metab Toxicol. 2014 Feb;10(2):175-89. doi: 10.1517/17425255.2014.856883. Epub 2013 Nov 9. Expert Opin Drug Metab Toxicol. 2014. PMID: 24205916 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page